These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 792409)

  • 1. Interaction of E. coli strains with human serum: lack of relationship to K1 antigen.
    Björkstén B; Bortolussi R; Gothefors L; Quie PG
    J Pediatr; 1976 Dec; 89(6):892-7. PubMed ID: 792409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Capsular K1 polysaccharide of Escherichia coli: relationship to virulence in newborn rats and resistance to phagocytosis.
    Bortolussi R; Ferrieri P; Björkstén B; Quie PG
    Infect Immun; 1979 Jul; 25(1):293-8. PubMed ID: 383617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review: relation between invasiveness and the K1 capsular polysaccharide of Escherichia coli.
    Schiffer MS; Oliveira E; Glode MP; McCracken GH; Sarff LM; Robbins JB
    Pediatr Res; 1976 Feb; 10(2):82-7. PubMed ID: 1107953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neonatal meningitis due of Escherichia coli K1.
    Glode MP; Sutton A; Robbins JB; McCracken GH; Gotschlich EC; Kaijser B; Hanson LA
    J Infect Dis; 1977 Aug; 136 Suppl():S93-7. PubMed ID: 330780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative contribution of ColV plasmid and K1 antigen to the pathogenicity of Escherichia coli.
    Agüero ME; Cabello FC
    Infect Immun; 1983 Apr; 40(1):359-68. PubMed ID: 6339405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of growth temperature of Escherichia coli on K1 capsular antigen production and resistance to opsonization.
    Bortolussi R; Ferrieri P; Quie PG
    Infect Immun; 1983 Mar; 39(3):1136-41. PubMed ID: 6341228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of human serum and neutrophils with Escherichia coli strains: differences between strains isolated from urine of patients with pyelonephritis or asymptomatic bacteriuria.
    Björkstén B; Kaijser B
    Infect Immun; 1978 Nov; 22(2):308-11. PubMed ID: 365753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of Escherichia coli K1 in healthy and diseased newborns.
    Sarff LD; McCracken GH; Schiffer MS; Glode MP; Robbins JB; Orskov I; Orskov F
    Lancet; 1975 May; 1(7916):1099-104. PubMed ID: 49468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative opsonic and protective activities of antibodies against K1, O and lipid A antigens of Escherichia coli.
    Welch WD; Martin WJ; Stevens P; Young LS
    Scand J Infect Dis; 1979; 11(4):291-301. PubMed ID: 93778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficient alternative complement pathway activity in newborn sera.
    Mills EL; Björksteń B; Quie PG
    Pediatr Res; 1979 Dec; 13(12):1341-4. PubMed ID: 392430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunologic regulation of E. coli K1 by serum from neonatal rats is enhanced following intraperitoneal administration of human IgG.
    Lassiter HA; Christensen RD; Parker CJ
    J Infect Dis; 1989 Mar; 159(3):518-25. PubMed ID: 2644382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The sensitivity of escherichia coli strains with K1 surface antigen and rods without this antigen to the bactericidal effect of serum.
    Cisowska A; Jankowski S
    Folia Microbiol (Praha); 2004; 49(4):471-8. PubMed ID: 15530015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Escherichia coli K5 antigen in relation to various infections and in healthy individuals.
    Kaijser B; Jodal U
    J Clin Microbiol; 1984 Feb; 19(2):264-6. PubMed ID: 6199369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Degree of antibody-independent activation of the classical complement pathway by K1 Escherichia coli differs with O antigen type and correlates with virulence of meningitis in newborns.
    Pluschke G; Achtman M
    Infect Immun; 1984 Feb; 43(2):684-92. PubMed ID: 6198283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. K1, K5 and O antigens of Escherichia coli in relation to serum killing via the classical and alternative complement pathways.
    Devine DA; Roberts AP
    J Med Microbiol; 1994 Aug; 41(2):139-44. PubMed ID: 7519270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Murine hybridoma antibodies enhance bactericidal activity of human cord blood against K1 Escherichia coli strains.
    Kim KS; Cross AS; Kaufmann B; Zollinger W; Sadoff J
    Pediatr Res; 1990 Dec; 28(6):667-70. PubMed ID: 1704500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic effect of cefotaxime and normal human serum on bactericidal activity against urinary strains of Escherichia coli with capsular antigen K1.
    Franiczek R; Jankowski S
    Acta Microbiol Pol; 1993; 42(3-4):243-50. PubMed ID: 7516615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Escherichia coli in bacteremia: K and O antigens and serum sensitivity of strains from adults and neonates.
    McCabe WR; Kaijser B; Olling S; Uwaydah M; Hanson LA
    J Infect Dis; 1978 Jul; 138(1):33-41. PubMed ID: 355575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mechanisms of activation of normal human serum complement by Escherichia coli strains with K1 surface antigen.
    Bugla-Płoskońska G; Cisowska A; Karpińska K; Jankowski S; Doroszkiewicz W
    Folia Microbiol (Praha); 2006; 51(6):627-32. PubMed ID: 17455802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opsonic and protective activity of immunoglobulin, modified immunoglobulin, and serum against neonatal Escherichia coli K1 infection.
    Bortolussi R; Fischer GW
    Pediatr Res; 1986 Feb; 20(2):175-8. PubMed ID: 3511443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.